PERSPECTA

News from every angle

← Back to headlines

Incyte Secures $120 Million AI Deal for Drug Development

Incyte has finalized a $120 million deal focused on utilizing artificial intelligence for drug development.

20 May, 16:00 — 20 May, 16:00
PostShare

Sources

Showing 1 of 1 sources
forbes104d ago

Inside Incyte’s $120 Million AI For Drug Development Deal - Forbes

Inside Incyte’s $120 Million AI For Drug Development Deal  Forbes

Read full article →

Related Stories

Apple Appoints John Ternus as New CEO Following Tim Cook’s Departure

1h ago

Apple Accuses OpenAI of Destroying Evidence in Trade Secrets Case

1h ago

Russia’s Domestic Starlink Competitor Fails After Launch Setback

2h ago

Waymo and Zoox Expand Commercial Robotaxi Services Across U.S. Cities

2h ago